Reference : Nuclear imaging methods for non-invasive drug monitoring.
Scientific journals : Article
Human health sciences : Radiology, nuclear medicine & imaging
http://hdl.handle.net/2268/18960
Nuclear imaging methods for non-invasive drug monitoring.
English
Bhatnagar, A. [> > > >]
Hustinx, Roland mailto [Université de Liège - ULg > Département des sciences cliniques > Médecine nucléaire >]
Alavi, A. [> > > >]
2000
Advanced Drug Delivery Reviews
41
1
41-54
International
0169-409X
NETHERLANDS
[en] Drug Monitoring ; Fluorodeoxyglucose F18/metabolism ; Humans ; Neoplasms/metabolism ; Radioimmunodetection ; Radioimmunotherapy ; Radionuclide Imaging ; Receptors, Cell Surface/analysis ; Tomography, Emission-Computed ; Tomography, Emission-Computed, Single-Photon
[en] Functional imaging techniques provide complimentary information to that provided by structural studies such as MRI and CT. Functional imaging is based upon known parameters such as physiology, metabolism, biochemistry, pharmacology, and any other biological process. As such, this methodology plays a major role in understanding the basic mechanisms of a multitude of disorders, accurate diagnosis of certain diseases, and developing effective treatment for serious illnesses such as cancer and central nervous system maladies. Although this type of imaging can be performed with various modalities, nuclear procedures have played the leading role in this discipline. Advances made in labeling various radionuclides to biologically important compounds, and development of sophisticated instruments have substantially contributed to the growth of the field of functional imaging. The introduction of positron emission topography (PET), which is based on imaging of compounds labeled with elements such as carbon, nitrogen, and fluorine, has added a major dimension to the evolution of the discipline. This review deals with a brief introduction to the methodologies utilized with radiolabeled tracers and then deals with specific applications of this technology. These applications include assessment of blood flow and metabolism, receptor imaging, elucidating the pathophysiologic process, evaluating role of labeled therapeutic agents, and the potential of these techniques in the development of novel biologic therapies. Functional imaging with radiolabeled tracers will play an increasingly important role in modern medicine, and its impact will be substantial in the management of patients with various disorders.
http://hdl.handle.net/2268/18960

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
Bhatnagar A et al, Adv Drug Deliv Rev 2000.pdfNo commentaryPublisher postprint687.62 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.